Mergers and acquisitions – Page 8
-
BusinessBASF boosts coatings with Chemetall buyout
$3.2bn purchase from Albemarle continues BASF’s efforts to expand and refocus its coatings division
-
BusinessWestlake Chemical to buy rival Axiall
US chemical manufacturer Axiall acquired by Westlake Chemical for $3.8 billion, after its earlier bid was rejected
-
Business
Merck & Co to buy Afferent for neurology drugs
Deal worth up to $1.25bn includes drug candidate for chronic coughs
-
BusinessJ&J to buy Vogue for haircare range
$3.3bn deal expands Johnson & Johnson’s consumer products segment
-
BusinessThermoFisher Scientific to buy electron microscope maker
Deal will expand lab equipment provider’s instrument portfolio for life and materials sciences
-
BusinessJazz Pharma buy out Celator in $1.5bn deal
Deal centres on promising leukaemia drug fast-tracked by the US Food and Drug Administration
-
BusinessUS tax rules force fertiliser merger to fall flat
CF Industries’ $8bn merger plan to relocate from US to Europe scuppered by regulatory changes
-
BusinessMonsanto turns down Bayer offer
As global agrochemical companies consolidate, Monsanto rejects ‘inadequate’ $62bn offer from Bayer
-
BusinessMylan expands in dermatology
$1bn deal with Renaissance Acquisition Holdings brings 25 products and builds on Meda merger portfolio
-
BusinessPfizer to buy Anacor for eczema ointment
$5.2bn deal will bolster pharma giant’s inflammation and immunology drugs portfolio
-
Business
Honeywell spins off resins and chemicals unit
‘AdvanSix’ will separate by early 2017 and produce nylon, fertiliser and various chemical intermediates
-
Business
Total to buy Saft for battery boost
€950m deal pushes French oil giant deeper into renewables
-
BusinessEvonik acquires Air Products’ chemical unit
Air Products also spinning off electronic materials to focus on industrial gases
-
BusinessDaiichi Sankyo awarded damages from former Ranbaxy owners
Arbitration says Singh family withheld information about regulatory investigations during Ranbaxy takeover
-
BusinessAbbot boosts heart devices with St Jude buyout
Medical devices consolidation continues with $25bn deal, but Abbott expresses concerns over proposed Alere merger
-
BusinessCancer deals spread
AbbVie nabs antibody specialist Stemcentrx, while Sanofi pursues Medivation
-
BusinessChemours sheds disinfectants and aniline
Dow Chemical and Germany’s Lanxess will buy plants as Chemours restructures following its spin-off from DuPont
-
BusinessUS treasury rules scupper Pfizer–Allergan merger
Government aims to crack down on corporate tax avoidance through ‘inversion’ deals
-
BusinessRoche sketches out Blueprint collaboration
Drug discovery startup will contribute to cancer immunotherapy projects aimed at kinase enzymes
-
BusinessSanofi and Merck & Co end vaccines partnership
Two-decade-long alliance will split by end of 2016